- Review
- Korean J Med. 2005;69(1):150-150.
- Extended study topotecan, idarubicin, and intermediate-dose cytarabine combination chemotherapy in patients with refractory or relapsed acute myelogenous leukemia and high-risk myelodysplastic syndrome
- Jin Seok Kim
- .
- .
- Abstract
- .
Keywords :
